GHN Pharma

GHN Pharma is a UK-based specialty pharmaceutical company that focuses on the sourcing, registration, and distribution of niche and essential medicines globally. The company specializes in providing access to unlicensed medicines through Named Patient programs and managing a portfolio of hard-to-source generic and branded pharmaceuticals. GHN Pharma serves a diverse range of therapeutic areas, including oncology, critical care, and rare diseases, ensuring that healthcare providers can access critical treatments. Their business model emphasizes regulatory compliance and supply chain excellence to bridge gaps in medicine availability. They operate as a key link between pharmaceutical manufacturers and healthcare institutions in underserved or complex markets.